kidney 2 Flashcards

1
Q

Antihypertensive Agents

A
  • ACE-Inhibitors, -Adrenergic blockers, Angiotensin II Receptor Blockers
    • Can increase serum K levels
  • Ca Channel Blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diuretics

A

-K sparing or K losing, depending on type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lipid Lowering Agents (people with chronic kidney desease are more at risk for coronary heart disease

A

e.g. Statins, Fibrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phosphorus Binders

–IF SERUM [PHOSPHATE] ELEVATED.

A
-Take with meals to bind phosphate and prevent its absorption from the GIT.
—Aluminum Based
	-Amphojel & Basaljel
—Calcium Based
	-Oscal & Tums
—Non-Aluminum, Non-Calcium (NANC) Based
	-Renagel & Fosrenol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vitamin D Analogues (often later stages)

A

e. g. Calcitriol

- as 1,25 dihydroxycholecalciferol since kidney cannot efficiently hydroxylate 25-OH cholecalciferol at the 1-postion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sodium polystyrene sulfonate

A

-a cation-exchange resin to bind K.

IF SERUM K IS HIGH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diuretics

A
  • Potassium sparing (e.g. spironolactone/Aldactone)

- Potassium wasting (e.g. furosemide/Lasix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anemia Management SIGNIFICANT PROBLME IN CHRONIC KIDNEY DISEASE
-Causes:
treatment

A

a)  erythropoietin production  erythrocyte production = major cause
b) (later) blood losses associated with dialysis and laboratory tests may contribute.
c) dietary factors – poor intake-may contribute.

Treatment:
—Human recombinant erythropoietin
	Eprex or Aransep 
—Adequate nutritional support for the increased erythrocyte production
Iron 
B12
Folate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
NUTRITIONAL CARE
Nutritional recommendations vary for:
•	acute renal disease 
•	chronic  kidney disease
	-Stages 1-4
	-Stage 5- renal replacement therapy
		-hemodialysis
		-peritoneal dialysis
		-renal transplantation
			Hemodialysis
			Renal transplantation
A

j

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

-Objectives of nutritional care:

A
  1. Maintain optimum nutritional status.
  2. Minimize metabolic disorders & related symptoms:
    i) reduce intake of substances that the kidney can no longer excrete well
    ii) provide replacements for compounds lost in  quantities.
  3. Retard progression of disease: help people with overweight or obesity

Individualize guidelines for each patient throughout care. Based on blood work and history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Protein-energy malnutrition is a very common problem in those with advanced chronic kidney or in those undergoing dialysis.

There are many causes:

A

• Poor food intake due to:
o Anorexia caused by uremia (don’t feel like eating)
o Altered taste
o Unpalatable prescribed diets
• Catabolic response to the illness and chronic inflammation
• Dialysis causes loss of some nutrients and promotes protein catabolism
• Endocrine disorders of uremia (high wate products in the blood) (e.g. resistance to insulin and IGF [insulin-like growth factor])
• Accumulation of uremic toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nutritional Care: Stages 1-4
= the stage prior to dialysis, transplantation.

Protein
HOW MUCH? CONSULT TABLES

A

Note the difference between Stage 3&4. – look at tables. Prn – as required

-With progression through stages 1 through 4, endproducts of protein metabolism are not being eliminated normally in the urine (uremia).

  • Consider all sources of these endproducts:
    1) Exogenous protein intake:  with  dietary protein

2) Endogenous protein breakdown.
-Factors that  muscle catabolism  uremia:
• inadequate energy intake
• inadequate protein intake
• unbalanced protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

-How do we deal with these metabolic alterations from a nutritional point of view?-Recommendations intended to:

A
  • Aim: Do not provide excess protein to prevent accumulation of endproducts + maintain N balance.
  • i.e. match the dietary protein to the workload capability of the kidneys.
  • Note small increase in protein requirement in earlier stages related to issues described above for protein-energy malnutrition.

• prevent symptoms associated with uremia  nausea, vomiting, fatigue.

• delay progression of kidney disease.
[evidence from Modification of Diet in Renal Disease (MDRD Study) and others].
Know the g/kg… on tables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Energy
HOW MUCH? CONSULT THE TABLES. BUT, assessment of individual energy requirement required- stays the same in each stage
WHY THE DIFFERENCE BY AGE?
How to assess whether you are meeting protein and energy needs:

A

BMR goes down

-protein recommendations assume energy needs are met by nonprotein sources.
-important to meet energy requirements and minimize endogenous protein catabolism to supply energy.
a) accumulation of protein breakdown products
e.g. serum [urea] –but note it is nonspecific, being affected by:
• renal function  serum [urea]
• protein intake  serum [urea]
• inadequate energy intake  serum [urea]

b) nutritional assessment tests of protein and energy status
-biochemical and anthropometric assessment
-Appropriateness of level of protein intake is continually assessed and adjusted as required.
Biochemical and anthropometric assessment
Biochemical: would serum [albumin] be useful? Its going to go down so wont tell as much about nutritional status as we would like
Example of anthropometric measurement?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fluid

A

HOW MUCH? NOTE CHANGE BETWEEN STAGES 1/2 AND 3/4. WHY?
½ stage: stay well hydrate
3- stay hydrated but restrict as needed
4- stay hydrated but restrict as needed
If dietary Na diminishes, thirst often decreases appropriately.

  • IF DIETARY Na DIMINISHES, THIRST OFTEN DECREASES APPROPRIATELY.
  • BUT, as urine output declines, may come a time when fluid has to be restricted to equal fluid loss. E. g. Volume of urine output for previous day + ~1000 ml to compensate for nonurinary losses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phosphorus and Calcium

A

HOW MUCH? NOTE CHANGE BETWEEN STAGES 1/2 AND 3/4.
½ calcium: DRI, phosphorus: unrestricted
3/4: calcium: avoid/treat symptomatic hypocalcemie ; <2000mg (diet + supplements) phosphorus: 800-1000mg ideal up to 1200mg if PO4 normal and nutritional status warrants (decrease protein)
Note all sources of Ca being considered.

17
Q

Why the increase in recommended protein intake, compared with stages 1-4? for 5

A

1) Dialysis assists with getting rid of metabolic endproducts.
2) Some extra protein losses:
- Some loss into the dialysate during each session (further increases with peritonitis(increase protein loss) in peritoneal dialysis).
- Accelerated protein catabolism due to dialysis.

18
Q

What other recommendations change at Stage 5? CONSULT TABLES

LET’S THINK ABOUT WHY

A

Stage 5: 1.2g/kg for HD, 1.2-1.3G/Kg (PD); 50% HBV
Energy stays the same
Soium: same
Potassium: restriction is typical on HD, but of PD more liberal as more is loss
Phosphorus: 800-1000 is ideal, however, increased protein requirement will make restriction more challenging
Vit/min: same
Fluids: 1-1.5L on HD; more liberal on peritoneal dialysis

19
Q

Some Transplant-Related Problems with Nutritional Implications

A
  1. Carbohydrate intolerance
  2. Increased protein catabolism during early posttransplant period
  3. Hypertension
  4. Increased drug-nutrient interactions
  5. Obesity
  6. Hyperlipidemia
  7. Hyperkalemia
  8. Calcium and Phosphorus Concerns